Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FDA clears new indication for Rythmol

Jan. 15, 1998

Kyowa Hakko characterizes new MLCK inhibitors from soil fungus

Jan. 15, 1998

Texas Biotechnology prepares new endothelin modulators

Jan. 15, 1998

AHC-52, a new dihydropyridine with cardioprotective effects

Jan. 14, 1998

Novel ET antagonists claimed by BASF

Jan. 14, 1998

New use approved for Lescol

Jan. 14, 1998

ProAmatine filed for approval in U.K.

Jan. 13, 1998

Lusofarmaco develops new angiotensin antagonists

Jan. 13, 1998

Efficacy established for ET antagonist in pulmonary hypertension

Jan. 13, 1998

Ketoacid ETA antagonists from Warner-Lambert

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...